Brief India: Middle East Risk Premium Is Back – The Commodity Shock That Reshapes Sector Winners and more
In this briefing: Middle East Risk Premium Is Back – The Commodity Shock That Reshapes Sector Winners APAC Healthcare Weekly (March 8) – Sino Bio, Antengene, Takeda, Sumitomo Pharma, ABL Bio, Glenmark Karnataka's Massive Policy Shift: Who Benefits the Most in India's Alco-Bev Sector? KPIT Tech: Shift to a Solutions Led Approach Union Bank X BoI [Merger 2.0]: India's 2nd Largest Public Sector Bank in Making? 1. Middle East Risk Premium Is Back – The Commodity Shock That Reshapes Sector Winners The Commodity Shock Is Back: Middle East Tensions Lift Oil, Tankers and Fertilisers While Petrochemicals and Airlines Face Margin Squeeze Energy Risk Premium Returns: Oil Producers and Shipping Rally as Rising Feedstock and Fuel Costs Hit Petrochemicals, Airlines and Energy-Intensive Sectors From Conflict to Commodities: Middle East Tensions Reprice Oil, Shipping and Fertilisers While Downstream Industries Bear the Cost 2. APAC Healthcare Weekly (March 8) – Sino Bio, Antengene, Takeda, Sumitomo Pharma, ABL Bio, Glenmark Sino Biopharmaceutical entered outlicensing agreement with Sanofi for rovadicitinib for upfront payment of $135M.